The role of health systems factors in facilitating access to psychotropic medicines: a cross-sectional analysis of the WHO-AIMS in 63 low- and middle-income countries.

<h4>Background</h4>Neuropsychiatric conditions comprise 14% of the global burden of disease and 30% of all noncommunicable disease. Despite the existence of cost-effective interventions, including administration of psychotropic medicines, the number of persons who remain untreated is as...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ryan McBain, Daniel J Norton, Jodi Morris, M Taghi Yasamy, Theresa S Betancourt
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2012
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/c068df070de74b75a6fb2dbfe8245a62
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c068df070de74b75a6fb2dbfe8245a62
record_format	dspace
spelling	oai:doaj.org-article:c068df070de74b75a6fb2dbfe8245a622021-11-18T05:42:22ZThe role of health systems factors in facilitating access to psychotropic medicines: a cross-sectional analysis of the WHO-AIMS in 63 low- and middle-income countries.1549-12771549-167610.1371/journal.pmed.1001166https://doaj.org/article/c068df070de74b75a6fb2dbfe8245a622012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22303288/pdf/?tool=EBIhttps://doaj.org/toc/1549-1277https://doaj.org/toc/1549-1676<h4>Background</h4>Neuropsychiatric conditions comprise 14% of the global burden of disease and 30% of all noncommunicable disease. Despite the existence of cost-effective interventions, including administration of psychotropic medicines, the number of persons who remain untreated is as high as 85% in low- and middle-income countries (LAMICs). While access to psychotropic medicines varies substantially across countries, no studies to date have empirically investigated potential health systems factors underlying this issue.<h4>Methods and findings</h4>This study uses a cross-sectional sample of 63 LAMICs and country regions to identify key health systems components associated with access to psychotropic medicines. Data from countries that completed the World Health Organization Assessment Instrument for Mental Health Systems (WHO-AIMS) were included in multiple regression analyses to investigate the role of five major mental health systems domains in shaping medicine availability and affordability. These domains are: mental health legislation, human rights implementations, mental health care financing, human resources, and the role of advocacy groups. Availability of psychotropic medicines was associated with features of all five mental health systems domains. Most notably, within the domain of mental health legislation, a comprehensive national mental health plan was associated with 15% greater availability; and in terms of advocacy groups, the participation of family-based organizations in the development of mental health legislation was associated with 17% greater availability. Only three measures were related with affordability of medicines to consumers: level of human resources, percentage of countries' health budget dedicated to mental health, and availability of mental health care in prisons. Controlling for country development, as measured by the Human Development Index, health systems features were associated with medicine availability but not affordability.<h4>Conclusions</h4>Results suggest that strengthening particular facets of mental health systems might improve availability of psychotropic medicines and that overall country development is associated with affordability.Ryan McBainDaniel J NortonJodi MorrisM Taghi YasamyTheresa S BetancourtPublic Library of Science (PLoS)articleMedicineRENPLoS Medicine, Vol 9, Iss 1, p e1001166 (2012)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R
spellingShingle	Medicine R Ryan McBain Daniel J Norton Jodi Morris M Taghi Yasamy Theresa S Betancourt The role of health systems factors in facilitating access to psychotropic medicines: a cross-sectional analysis of the WHO-AIMS in 63 low- and middle-income countries.
description	<h4>Background</h4>Neuropsychiatric conditions comprise 14% of the global burden of disease and 30% of all noncommunicable disease. Despite the existence of cost-effective interventions, including administration of psychotropic medicines, the number of persons who remain untreated is as high as 85% in low- and middle-income countries (LAMICs). While access to psychotropic medicines varies substantially across countries, no studies to date have empirically investigated potential health systems factors underlying this issue.<h4>Methods and findings</h4>This study uses a cross-sectional sample of 63 LAMICs and country regions to identify key health systems components associated with access to psychotropic medicines. Data from countries that completed the World Health Organization Assessment Instrument for Mental Health Systems (WHO-AIMS) were included in multiple regression analyses to investigate the role of five major mental health systems domains in shaping medicine availability and affordability. These domains are: mental health legislation, human rights implementations, mental health care financing, human resources, and the role of advocacy groups. Availability of psychotropic medicines was associated with features of all five mental health systems domains. Most notably, within the domain of mental health legislation, a comprehensive national mental health plan was associated with 15% greater availability; and in terms of advocacy groups, the participation of family-based organizations in the development of mental health legislation was associated with 17% greater availability. Only three measures were related with affordability of medicines to consumers: level of human resources, percentage of countries' health budget dedicated to mental health, and availability of mental health care in prisons. Controlling for country development, as measured by the Human Development Index, health systems features were associated with medicine availability but not affordability.<h4>Conclusions</h4>Results suggest that strengthening particular facets of mental health systems might improve availability of psychotropic medicines and that overall country development is associated with affordability.
format	article
author	Ryan McBain Daniel J Norton Jodi Morris M Taghi Yasamy Theresa S Betancourt
author_facet	Ryan McBain Daniel J Norton Jodi Morris M Taghi Yasamy Theresa S Betancourt
author_sort	Ryan McBain
title	The role of health systems factors in facilitating access to psychotropic medicines: a cross-sectional analysis of the WHO-AIMS in 63 low- and middle-income countries.
title_short	The role of health systems factors in facilitating access to psychotropic medicines: a cross-sectional analysis of the WHO-AIMS in 63 low- and middle-income countries.
title_full	The role of health systems factors in facilitating access to psychotropic medicines: a cross-sectional analysis of the WHO-AIMS in 63 low- and middle-income countries.
title_fullStr	The role of health systems factors in facilitating access to psychotropic medicines: a cross-sectional analysis of the WHO-AIMS in 63 low- and middle-income countries.
title_full_unstemmed	The role of health systems factors in facilitating access to psychotropic medicines: a cross-sectional analysis of the WHO-AIMS in 63 low- and middle-income countries.
title_sort	role of health systems factors in facilitating access to psychotropic medicines: a cross-sectional analysis of the who-aims in 63 low- and middle-income countries.
publisher	Public Library of Science (PLoS)
publishDate	2012
url	https://doaj.org/article/c068df070de74b75a6fb2dbfe8245a62
work_keys_str_mv	AT ryanmcbain theroleofhealthsystemsfactorsinfacilitatingaccesstopsychotropicmedicinesacrosssectionalanalysisofthewhoaimsin63lowandmiddleincomecountries AT danieljnorton theroleofhealthsystemsfactorsinfacilitatingaccesstopsychotropicmedicinesacrosssectionalanalysisofthewhoaimsin63lowandmiddleincomecountries AT jodimorris theroleofhealthsystemsfactorsinfacilitatingaccesstopsychotropicmedicinesacrosssectionalanalysisofthewhoaimsin63lowandmiddleincomecountries AT mtaghiyasamy theroleofhealthsystemsfactorsinfacilitatingaccesstopsychotropicmedicinesacrosssectionalanalysisofthewhoaimsin63lowandmiddleincomecountries AT theresasbetancourt theroleofhealthsystemsfactorsinfacilitatingaccesstopsychotropicmedicinesacrosssectionalanalysisofthewhoaimsin63lowandmiddleincomecountries AT ryanmcbain roleofhealthsystemsfactorsinfacilitatingaccesstopsychotropicmedicinesacrosssectionalanalysisofthewhoaimsin63lowandmiddleincomecountries AT danieljnorton roleofhealthsystemsfactorsinfacilitatingaccesstopsychotropicmedicinesacrosssectionalanalysisofthewhoaimsin63lowandmiddleincomecountries AT jodimorris roleofhealthsystemsfactorsinfacilitatingaccesstopsychotropicmedicinesacrosssectionalanalysisofthewhoaimsin63lowandmiddleincomecountries AT mtaghiyasamy roleofhealthsystemsfactorsinfacilitatingaccesstopsychotropicmedicinesacrosssectionalanalysisofthewhoaimsin63lowandmiddleincomecountries AT theresasbetancourt roleofhealthsystemsfactorsinfacilitatingaccesstopsychotropicmedicinesacrosssectionalanalysisofthewhoaimsin63lowandmiddleincomecountries
_version_	1718424812443926528

The role of health systems factors in facilitating access to psychotropic medicines: a cross-sectional analysis of the WHO-AIMS in 63 low- and middle-income countries.

Ejemplares similares